Items where authors include "Corbacioglu, S."

Article

Sanchez-Guijo, F. orcid.org/0000-0002-7076-7739, Vives, J. orcid.org/0000-0001-9719-5235, Ruggeri, A. et al. (15 more authors) (2024) Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT). Cytotherapy. ISSN 1465-3249

Styczynski, J. orcid.org/0000-0002-3158-119X, Tridello, G., Koster, L. et al. (25 more authors) (2023) Decrease of lethal infectious complications in the context of causes of death (COD) after hematopoietic cell transplantation: COD-2 and COD-1 study of the Infectious Diseases Working Party EBMT. Bone Marrow Transplantation. ISSN 0268-3369

Yakoub-Agha, I. orcid.org/0000-0003-4524-8782, Greco, R. orcid.org/0000-0002-6117-5328, Onida, F. et al. (14 more authors) (2023) Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy. Bone Marrow Transplantation. ISSN 0268-3369

Saccardi, R., Putter, H. orcid.org/0000-0001-5395-1422, Eikema, D.-J. et al. (45 more authors) (2023) Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplantation. pp. 1-8. ISSN 0268-3369

Passweg, J.R., Baldomero, H. orcid.org/0000-0002-6554-483X, Ciceri, F. et al. (12 more authors) (2023) Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT activity survey. Bone Marrow Transplantation. ISSN 0268-3369

Snowden, J.A. orcid.org/0000-0001-6819-3476, Sánchez-Ortega, I., Corbacioglu, S. et al. (17 more authors) (2022) Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transplantation. ISSN 0268-3369

Passweg, J.R., Baldomero, H., Chabannon, C. et al. (13 more authors) (2022) Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey. Bone Marrow Transplantation, 57. pp. 742-752. ISSN 0268-3369

Niederwieser, D., Baldomero, H., Bazuaye, N. et al. (33 more authors) (2022) One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors. Haematologica, 107 (5). pp. 1045-1053. ISSN 0390-6078

Hayden, P.J., Roddie, C., Bader, P. et al. (33 more authors) (2022) Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). Annals of Oncology, 33 (3). pp. 259-275. ISSN 0923-7534

Montoto, S., Snowden, J.A. orcid.org/0000-0001-6819-3476, Chabannon, C. et al. (19 more authors) (2022) The first steps towards a diverse and inclusive EBMT: a position paper. Bone Marrow Transplantation, 57 (3). pp. 343-346. ISSN 0268-3369

Passweg, J.R., Baldomero, H., Chabannon, C. et al. (13 more authors) (2021) Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transplantation, 56 (7). pp. 1651-1664. ISSN 0268-3369

Greco, R., Alexander, T., Burman, J. et al. (24 more authors) (2021) Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations. Bone Marrow Transplantation, 56. pp. 1493-1508. ISSN 0268-3369

Passweg, J.R., Baldomero, H., Basak, G.W. orcid.org/0000-0003-3858-8180 et al. (14 more authors) (2019) The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transplantation, 54 (10). pp. 1575-1585. ISSN 0268-3369

Duarte, R.F., Labopin, M., Bader, P. et al. (19 more authors) (2019) Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019. Bone Marrow Transplant, 54 (10). pp. 1525-1552. ISSN 0268-3369